Definition, identification and treatment of resistant hypertension in chronic kidney disease patients

Yelena R. Drexler, Andrew S. Bomback

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Resistant hypertension, the inability to achieve goal blood pressure despite the use of three or more appropriately dosed antihypertensive drugs (including a diuretic), remains a common clinical problem, especially in patients with chronic kidney disease (CKD). While the exact prevalence and prognosis of resistant hypertension in CKD patients remain unknown, resistant hypertension likely contributes significantly to increased cardiovascular risk and progression of kidney disease in this population. We review the identification and evaluation of patients with resistant hypertension, including the importance of 24-h ambulatory blood pressure monitoring in the identification of 'white-coat', 'masked' and 'non-dipper' hypertension, the latter of which has particular clinical and therapeutic importance in patients with resistant hypertension and CKD. We then discuss treatment strategies for resistant hypertension that target the pathophysiologic mechanisms underlying resistance to treatment, including persistent volume excess, incomplete renin-Angiotensin-Aldosterone system blockade and inadequate nocturnal blood pressure control. Finally, we propose a treatment algorithm for evaluation and treatment of resistant hypertension in patients with CKD.

Original languageEnglish (US)
Pages (from-to)1327-1335
Number of pages9
JournalNephrology Dialysis Transplantation
Volume29
Issue number7
DOIs
StatePublished - 2014
Externally publishedYes

Fingerprint

Chronic Renal Insufficiency
Hypertension
Therapeutics
Blood Pressure
Ambulatory Blood Pressure Monitoring
Kidney Diseases
Renin-Angiotensin System
Diuretics
Antihypertensive Agents
Population

Keywords

  • Algorithm
  • Chronic kidney disease
  • Resistant hypertension

ASJC Scopus subject areas

  • Nephrology
  • Transplantation

Cite this

Definition, identification and treatment of resistant hypertension in chronic kidney disease patients. / Drexler, Yelena R.; Bomback, Andrew S.

In: Nephrology Dialysis Transplantation, Vol. 29, No. 7, 2014, p. 1327-1335.

Research output: Contribution to journalArticle

@article{3b01550c4d84431290eb5686071b825f,
title = "Definition, identification and treatment of resistant hypertension in chronic kidney disease patients",
abstract = "Resistant hypertension, the inability to achieve goal blood pressure despite the use of three or more appropriately dosed antihypertensive drugs (including a diuretic), remains a common clinical problem, especially in patients with chronic kidney disease (CKD). While the exact prevalence and prognosis of resistant hypertension in CKD patients remain unknown, resistant hypertension likely contributes significantly to increased cardiovascular risk and progression of kidney disease in this population. We review the identification and evaluation of patients with resistant hypertension, including the importance of 24-h ambulatory blood pressure monitoring in the identification of 'white-coat', 'masked' and 'non-dipper' hypertension, the latter of which has particular clinical and therapeutic importance in patients with resistant hypertension and CKD. We then discuss treatment strategies for resistant hypertension that target the pathophysiologic mechanisms underlying resistance to treatment, including persistent volume excess, incomplete renin-Angiotensin-Aldosterone system blockade and inadequate nocturnal blood pressure control. Finally, we propose a treatment algorithm for evaluation and treatment of resistant hypertension in patients with CKD.",
keywords = "Algorithm, Chronic kidney disease, Resistant hypertension",
author = "Drexler, {Yelena R.} and Bomback, {Andrew S.}",
year = "2014",
doi = "10.1093/ndt/gft346",
language = "English (US)",
volume = "29",
pages = "1327--1335",
journal = "Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "7",

}

TY - JOUR

T1 - Definition, identification and treatment of resistant hypertension in chronic kidney disease patients

AU - Drexler, Yelena R.

AU - Bomback, Andrew S.

PY - 2014

Y1 - 2014

N2 - Resistant hypertension, the inability to achieve goal blood pressure despite the use of three or more appropriately dosed antihypertensive drugs (including a diuretic), remains a common clinical problem, especially in patients with chronic kidney disease (CKD). While the exact prevalence and prognosis of resistant hypertension in CKD patients remain unknown, resistant hypertension likely contributes significantly to increased cardiovascular risk and progression of kidney disease in this population. We review the identification and evaluation of patients with resistant hypertension, including the importance of 24-h ambulatory blood pressure monitoring in the identification of 'white-coat', 'masked' and 'non-dipper' hypertension, the latter of which has particular clinical and therapeutic importance in patients with resistant hypertension and CKD. We then discuss treatment strategies for resistant hypertension that target the pathophysiologic mechanisms underlying resistance to treatment, including persistent volume excess, incomplete renin-Angiotensin-Aldosterone system blockade and inadequate nocturnal blood pressure control. Finally, we propose a treatment algorithm for evaluation and treatment of resistant hypertension in patients with CKD.

AB - Resistant hypertension, the inability to achieve goal blood pressure despite the use of three or more appropriately dosed antihypertensive drugs (including a diuretic), remains a common clinical problem, especially in patients with chronic kidney disease (CKD). While the exact prevalence and prognosis of resistant hypertension in CKD patients remain unknown, resistant hypertension likely contributes significantly to increased cardiovascular risk and progression of kidney disease in this population. We review the identification and evaluation of patients with resistant hypertension, including the importance of 24-h ambulatory blood pressure monitoring in the identification of 'white-coat', 'masked' and 'non-dipper' hypertension, the latter of which has particular clinical and therapeutic importance in patients with resistant hypertension and CKD. We then discuss treatment strategies for resistant hypertension that target the pathophysiologic mechanisms underlying resistance to treatment, including persistent volume excess, incomplete renin-Angiotensin-Aldosterone system blockade and inadequate nocturnal blood pressure control. Finally, we propose a treatment algorithm for evaluation and treatment of resistant hypertension in patients with CKD.

KW - Algorithm

KW - Chronic kidney disease

KW - Resistant hypertension

UR - http://www.scopus.com/inward/record.url?scp=84903852674&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903852674&partnerID=8YFLogxK

U2 - 10.1093/ndt/gft346

DO - 10.1093/ndt/gft346

M3 - Article

C2 - 24046194

AN - SCOPUS:84903852674

VL - 29

SP - 1327

EP - 1335

JO - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

JF - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

SN - 0931-0509

IS - 7

ER -